• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Qiagen N.V. Common Shares (NY:QGEN)

40.10 +0.97 (+2.48%)
Official Closing Price Updated: 7:00 PM EDT, Jul 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,625,900
Open 40.00
Bid (Size) 33.77 (100)
Ask (Size) 44.50 (200)
Prev. Close 39.13
Today's Range 39.75 - 40.18
52wk Range 32.53 - 57.81
Shares Outstanding 227,985,334
Dividend Yield 0.62%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
June 15, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
June 02, 2026
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-11.3%
-11.3%
1 Month
+12.4%
+12.4%
3 Month
-2.3%
-2.3%
6 Month
-11.3%
-11.3%
1 Year
-17.6%
-17.6%

More News

Read More
News headline image
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 28, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
May 26, 2026
From Pomerantz LLP
Via GlobeNewswire
QIAGEN N.V. (NYSE:QGEN) Q1 Earnings Miss Estimates, Guidance Cut Sinks Stock ↗
May 06, 2026
Via Chartmill
Topics Earnings
News headline image
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.
May 21, 2026
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 20, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QGEN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Qiagen N.V.
May 19, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Qiagen N.V. - QGEN
May 19, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 19, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Qiagen N.V. on Behalf of Qiagen Stockholders and Encourages Investors to Contact the Firm
May 15, 2026
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
QGEN SHAREHOLDER ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
May 14, 2026
From Kirby McInerney LLP
Via GlobeNewswire
News headline image
QIAGEN N.V. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud
May 12, 2026
From Kirby McInerney LLP
Via Business Wire
News headline image
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
Water Utility Up Just 8% in a Year Faces $28 Million Position Cut ↗
May 09, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Qiagen (QGEN) Q1 2026 Earnings Transcript ↗
May 07, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 07, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QGEN Investors Have Opportunity to Join Qiagen N.V. Fraud Investigation with the Schall Law Firm
May 06, 2026
From Schall Law
Via GlobeNewswire
News headline image
QIAGEN Reports Full Results for Q1 2026
May 06, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN to Showcase New Sample to Insight Solutions for Complex Oncology Applications at AACR 2026
April 16, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Expands Into Bloodstream Infection Syndromic Testing With New Rapid QIAstat-Dx Panel
April 14, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
March 20, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
March 19, 2026
From QIAGEN N.V.
Via Business Wire
News headline image
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
March 10, 2026
From QIAGEN N.V.
Via Business Wire

Frequently Asked Questions

Is Qiagen N.V. Common Shares publicly traded?
Yes, Qiagen N.V. Common Shares is publicly traded.
What exchange does Qiagen N.V. Common Shares trade on?
Qiagen N.V. Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Qiagen N.V. Common Shares?
The ticker symbol for Qiagen N.V. Common Shares is QGEN on the New York Stock Exchange
What is the current price of Qiagen N.V. Common Shares?
The current price of Qiagen N.V. Common Shares is 40.10
When was Qiagen N.V. Common Shares last traded?
The last trade of Qiagen N.V. Common Shares was at 07/02/26 07:00 PM ET
What is the market capitalization of Qiagen N.V. Common Shares?
The market capitalization of Qiagen N.V. Common Shares is 9.14B
How many shares of Qiagen N.V. Common Shares are outstanding?
Qiagen N.V. Common Shares has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap